Title |
Post-influenza aspergillosis, do not underestimate influenza B
|
---|---|
Published in |
Infection and Drug Resistance, February 2017
|
DOI | 10.2147/idr.s122390 |
Pubmed ID | |
Authors |
Eric FL Nulens, Marc JC Bourgeois, Marijke BML Reynders |
Abstract |
Our objective is to highlight and focus on post-influenza aspergillosis, triggered by influenza B virus. This relatively new clinical entity is often associated with a fulminant course of respiratory decline and high mortality. A 51-year immunocompetent woman, without any medical history or risk factors for developing a complicated influenza infection, was admitted to the intensive care unit. During admission, she presented with an afebrile flu-like syndrome, myocarditis, rhabdomyolysis, multiple organ failure, and evolved to severe respiratory distress. The broncho-alveolar lavage contained influenza B RNA, and the culture revealed Aspergillus fumigatus. Despite maximal organ support, immunoglobulin, antiviral and antifungal therapy, the patient died. This case demonstrates that influenza B virus may be life threatening even to immunocompetent adults and may trigger an invasive Aspergillus superinfection. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 50 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 10 | 20% |
Student > Bachelor | 6 | 12% |
Student > Master | 5 | 10% |
Student > Doctoral Student | 4 | 8% |
Researcher | 4 | 8% |
Other | 5 | 10% |
Unknown | 16 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 36% |
Biochemistry, Genetics and Molecular Biology | 4 | 8% |
Nursing and Health Professions | 3 | 6% |
Immunology and Microbiology | 2 | 4% |
Veterinary Science and Veterinary Medicine | 1 | 2% |
Other | 5 | 10% |
Unknown | 17 | 34% |